Social and Clinical Impact of COVID-19 on Patients with Fibrodysplasia Ossificans Progressiva.
Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva.
Orphanet journal of rare diseases
Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
BMC musculoskeletal disorders